A Study to Investigate the Absolute Bioavailability, Absorption, Metabolism, Distribution and Excretion of [14C]AZD5363 (Capivasertib)

Trial Identifier:	D3614C00007
Sponsor:	AstraZeneca
Collaborator:	Quotient Sciences Ltd
NCTID::	NCT05419401
Start Date:	April 2022
Primary Completion Date:	July 2022
Study Completion Date:	July 2022
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version
	English (UK) Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
GB	Ruddington, GB, NG11 6JS

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.